Capstone Investment Advisors »

Zenas Biopharma shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 3.5M 1.04

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr China Lg-cap Etf (FXI)
Alphabet Cap Stk Cl A (GOOGL)
Lumentum Hldgs Note 1.500%12/1 (Principal)
Meta Platforms Cl A (META)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Western Digital Corp Note 3.000%11/1 (Principal)

View all positions for Capstone Investment Advisors

Top funds holding Zenas Biopharma

Deerfield Management Company
Context Capital Management
Jpmorgan Chase & Co
Braidwell
Jane Street
Citadel Advisors
Leucadia National Corporation
Capstone Investment Advisors
Monashee Investment Management
D. E. Shaw & Co
Calamos Advisors
Graham Capital Management
Woodline Partners
Millennium Management
Aristeia Capital

View all funds holding Zenas Biopharma